Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 MDS to Sell Diagnostics Business | Contract Pharma

What are you searching for?

Sign in
Breaking News

MDS to Sell Diagnostics Business

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

MDS, Inc. has signed an agreement to sell its Canadian Diagnostic Services business to Borealis Infrastructure Management, Inc. in a $1.2 billion transaction. This sale is part of the company’s strategic shift to focus on the life sciences market and streamline its cost structure to be more competitive.

“The sale of our diagnostics business represents a major milestone for MDS in the transition to a global life sciences company,” said Stephen P. DeFalco, president and chief executive officer, MDS. “We will be able to focus exclusively on life sciences markets, where incredible advances are being made to diagnose and treat diseases. This agreement represents a great outcome for our shareholders, our employees and the customers we serve.”

“We see an exciting future for this business,” said Michael Rolland, senior vice president of Borealis. “We look forward to working with the talented professional staff at MDS Diagnostic Services to ensure that they continue to lead the industry in the delivery of laboratory services that support the healthcare needs of Canadians.”

The transaction, subject to customary approvals and conditions, is expected to close by the end of January 2007.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters